Metabolism of synthetic corticosteroids by 11β-hydroxysteroid- dehydrogenases in man

Steroids

Volumn 63, Issue 5-6, 1998, Pages 271-277

  Diederich, Sven ^a   Hanke, Bert ^b   Burkhardt, Patrick ^b   Müller, Markus ^b   Schöneshöfer, Manfred ^b   Bähr, Volker ^b   Oelkers, Wolfgang ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b NONE

Author keywords

11 hydroxysteroid dehydrogenase; 9 fluorocortisol; Dexamethasone; Glucocorticoid targeting; Isoenzymes; Kinetics

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; ISOENZYME;

CONFERENCE PAPER; CORTICOSTEROID METABOLISM; ENZYME KINETICS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY MICROSOME; LIVER MICROSOME; MALE; NORMAL HUMAN; OXIDATION; REDUCTION; STEROID URINE LEVEL;

ADRENAL CORTEX HORMONES; HUMANS; KIDNEY; MICROSOMES, LIVER; NAD; NADP;

EID: 0032076302     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(98)00039-7     Document Type: Conference Paper

References (32)

1. 1. Bush IE (1962). Chemical and biologic factors in the activity of adrenocortical steroids. Pharmacol Rev 14:317-445.
2. 2. Frey FJ, Escher G, Frey BM (1994). Pharmacology of 11 beta-hydroxysteroid dehydrogenase. Steroids 59:74-79.
3. 3. Ballard PL, Carter JP, Graham BS, Baxter JD (1975). A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man. J Clin Endocrinol Metab 41:290-304.
4. 4. Funder JW (1989). How can aldosterone act as a mineralocorticoid? Endocr Res 15:227-238.
5. 5. Ruers TJ, Buurman WA, Smits JF, van der Linden CJ, van Dongen JJ, Struyker Boudier HA, Kootstra G (1986). Local treatment of renal allografts, a promising way to reduce the dosage of immuno-suppressive drugs. Transplantation 41:156-161.
6. 6. Ruers TJ, Buurman WA, van Boxtel CJ, van der Linden CJ, Kootstra G (1987). Immunohistological observations in rat kidney allo-grafts after local steroid administration. J Exp Med 166:1205-1220.
7. 7. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C (1988). Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2:986-989.
8. 8. Funder JW, Pearce PT, Smith R, Smith AI (1988). Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science (Washington DC) 242:583-585.
9. 9. Tannin GM, Agarwal AK, Monder C, New MI, White PC (1991). The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J Biol Chem 266:16653-16658.
10. 10. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS (1994). Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105:R11-R17.
11. 11. Seckl JR (1993). 11 beta-hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation. Eur J Clin Invest 23:589-601.
12. 12. Low SC, Chapman KE, Edwards CR, Seckl JR (1994). 'Liver-type' 11 beta-hydroxysteroid dehydrogenase cDNA encodes reductase but not dehydrogenase activity in intact mammalian COS-7 cells. J Mol Endocrinol 13:167-174.
13. 13. Jamieson PM, Chapman KE, Edwards CRW, Seckl JR (1995). 11β-hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: Effect of physiochemical and hormonal manipulations. Endocrinology 136:4754-4761.
14. 14. Stewart PM, Murry BA, Mason JI (1994). Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform. J Clin Endocrinol Metab 79:480-484.
15. 15. Schöneshöfer M, Kage A, Weber B, Lenz I, Kottgen E (1985). Determination of urinary free cortisol by "on-line" liquid chromatography. Clin Chem 31:564-568.
16. 16. Oelkers W, Buchen S, Diederich S, Krain J, Muhme S, Schöneshöfer M (1994). Impaired renal 11-beta-oxidation of 9 alpha-fluorocortisol: An explanation for its mineralocorticoid potency. J Clin Endocrinol Metab 78:928-932.
17. 17. Diederich S, Hanke B, Oelkers W, Bähr V (1997). Metabolism of dexamethasone in the human kidney: Nicotinamide adenine dinucleotide-dependent 11β-reduction. J Clin Endocrinol Metab 82:1598-1602.
18. 18. Gaignage P, Lognay G, Marlier M, Severin M, Dreze P (1989). Applications of chromatographic and spectometric techniques to the study of dexamethasone related compounds. Chromatographia 28: 623-630.
19. 19. Diederich S, Quinkler M, Miller K, Heilmann P, Schöneshöfer M, Oelkers W (1996). Human kidney 11beta-hydroxysteroid dehydrogenase: Regulation by adrenocorticotropin? Eur J Endocrinol 134: 301-307.
20. 20. Atkins GL, Nimmo IA, Newman PF (1974). A comparison of seven methods for fitting the Michaelis-Menten equation. Biochem J 143: 779-781.
21. 21. Houston JB (1994). Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 47: 1469-1479.
22. 22. Oelkers W, Diederich S, Bähr V (1992). Diagnosis and therapy surveillance in Addison's disease: Rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab 75:259-264.
23. 23. Krozowski ZS, Funder JW (1983). Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80:6056-6060.
24. 24. Fried J, Borman A (1958). Synthetic derivates of cortical hormones. Vitam Horm 16:303-374.
25. 25. Ferrari P, Smith RE, Funder JW, Krozowski ZS (1996). Substrate and inhibitor specificity of the cloned human 11β-hydroxysteroid dehydrogenase type 2 isoform. Am J Physiol Endocrinol Metab 270:E900-E904.
26. 26. Best R, Nelson SM, Walker BR (1997). Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11β-hydroxysteroid dehydrogenase in vitro and in vivo. J Endocrinol 153:41-48.
27. 27. Abel SM, Back DJ, Maggs JL, Park BK (1993). Cortisol metabolism by human liver in vitro-IV. Metabolism of 9 alpha-fluorocortisol by human liver microsomes and cytosol. J Steroid Biochem Mol Biol 46:833-839.
28. 28. Rupprecht R, Arriza JL, Spengler D, Reul JM, Evans RM, Holsboer F, Damm K (1993). Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Mol Endocrinol 7:597-603.
29. 29. Lan NC, Graham B, Bartter FC, Baxter JD (1982). Binding of steroids to mineralocorticoid receptors: implications for in vivo occupancy by glucocorticoids. J Clin Endocrinol Metab 54:332-342.
30. 30. Siebe H, Baude G, Lichtenstein I, Wang D, Buhler H, Hoyer GA, Hierholzer K (1993). Metabolism of dexamethasone: Sites and activity in mammalian tissues. Renal Physiol Biochem 16:79-88.
31. 31. Li KXZ, Obeyesekere VR, Krozowski ZS, Ferrari P (1997). Oxoreductase and dehydrogenase activities of the human and rat 11β-hydroxysteroid dehydrogenase type 2 enzyme. Endocrinology 138: 2948-2952.
32. 32. Brown RW, Chapman KE, Kotelevtsev Y, Yau JLW, Lindsay RS, Brett L, Leckie C, Murad P, Lyons V, Mullins JJ, Edwards CRW, Seckl JR (1996). Cloning and production of antisera to human placental 11β-hydroxysteroid dehydrogenase type 2. Biochem J 313:1007-1017.